This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Coty Inc. Supports Delete Blood Cancer UK

WIMBLEDON, England, March 18, 2013 /PRNewswire/ --  Coty Inc., an emerging leader in beauty, is pleased to announce its latest initiative in support of Delete Blood Cancer/DKMS: the Feb. 19, 2013, launch of the organization in the U.K. With the Coty-Delete Blood Cancer/DKMS: Linked Against Blood Cancer partnership, Coty has backed Delete Blood Cancer/DKMS (the world's largest bone marrow-donor center) since its inception, by former Coty chairman and DKMS co-founder Peter Harf.

(Photo: http://photos.prnewswire.com/prnh/20130318/HS78551)

"Coty is very proud to help Delete Blood Cancer/DKMS reach new potential donors in the U.K.," said Mr. Michele Scannavini, CEO of Coty Inc. "Coty cares about giving back to the communities we're a part of, and our long and rich history of supporting Delete Blood Cancer/DKMS is just one way that we put our beliefs into action."

"We are grateful for the tremendous level of assistance that we've received from Coty over the years," said Harf. "It is a cause that is very dear to so many people around the world, and it has meant so much to Delete Blood Cancer/DKMS to have the power of Coty behind us as we have built our marrow-donor registry."

The partnership between Coty and Delete Blood Cancer/DKMS has been a long and illustrious one. Some of the key milestones have been Coty's help incorporating and expanding DKMS in the U.S. in 2004, including providing the organization with administrative and legal support, as well as office space in New York; Coty's support of the 2009 launch of DKMS Polska; and the 2011 registration of DKMS' 2.5 millionth donor in Germany, which occurred at Coty's office in Mainz. Perhaps most important has been Coty's ongoing fundraising support for the Delete Blood Cancer/DKMS annual gala, a star-studded event that has raised more than $9 million since it was first held, in 2006.

To mark the U.K. launch, Coty donated £10,000 and conducted donor drives at three of its U.K. facilities: Ashford, Henwood and Wimbledon. More than 200 potential donors were enlisted through the drives, which provided the successful culmination of the U.K. launch.

The U.K. events are just the latest employee donor drives facilitated by Coty at many of its offices throughout the world. More than 1,000 Coty employees globally have registered as potential bone marrow donors with Delete Blood Cancer/DKMS. Through the Coty-Delete Blood Cancer/DKMS: Linked Against Blood Cancer partnership, Coty covers donor registration fees for all Coty employees.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs